PT3661503T - Agentes antifúngicos com maior actividade em ph ácido - Google Patents

Agentes antifúngicos com maior actividade em ph ácido

Info

Publication number
PT3661503T
PT3661503T PT187556329T PT18755632T PT3661503T PT 3661503 T PT3661503 T PT 3661503T PT 187556329 T PT187556329 T PT 187556329T PT 18755632 T PT18755632 T PT 18755632T PT 3661503 T PT3661503 T PT 3661503T
Authority
PT
Portugal
Prior art keywords
acidic
antifungal agents
enhanced activity
enhanced
activity
Prior art date
Application number
PT187556329T
Other languages
English (en)
Original Assignee
Scynexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=63209698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3661503(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scynexis Inc filed Critical Scynexis Inc
Publication of PT3661503T publication Critical patent/PT3661503T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT187556329T 2017-08-04 2018-07-31 Agentes antifúngicos com maior actividade em ph ácido PT3661503T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762541370P 2017-08-04 2017-08-04

Publications (1)

Publication Number Publication Date
PT3661503T true PT3661503T (pt) 2022-12-13

Family

ID=63209698

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187556329T PT3661503T (pt) 2017-08-04 2018-07-31 Agentes antifúngicos com maior actividade em ph ácido

Country Status (26)

Country Link
US (3) US11534433B2 (pt)
EP (3) EP4732902A2 (pt)
JP (1) JP7214714B2 (pt)
KR (1) KR102807716B1 (pt)
CN (2) CN111093655A (pt)
AU (2) AU2018309718B2 (pt)
BR (1) BR112020002290A2 (pt)
CA (1) CA3071940A1 (pt)
CY (1) CY1125690T1 (pt)
DK (1) DK3661503T3 (pt)
EA (1) EA202090445A1 (pt)
ES (1) ES2932658T3 (pt)
FI (1) FI3661503T3 (pt)
HR (1) HRP20221414T1 (pt)
HU (1) HUE060508T2 (pt)
LT (1) LT3661503T (pt)
MA (1) MA49751B1 (pt)
MD (1) MD3661503T2 (pt)
MX (1) MX2020001399A (pt)
PL (1) PL3661503T3 (pt)
PT (1) PT3661503T (pt)
RS (1) RS63746B1 (pt)
SI (1) SI3661503T1 (pt)
SM (1) SMT202200461T1 (pt)
TW (1) TWI805600B (pt)
WO (1) WO2019028034A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA55081A (fr) * 2019-02-27 2022-01-05 Scynexis Inc <smallcaps/>? ? ?pneumocystis? ? ? ? ?antifongiques triterpénoïdes pour le traitement ou la prévention de la pneumonie àspp
BR112021022876A2 (pt) * 2019-05-16 2022-04-12 Scynexis Inc Método para descolonizar candida auris de uma área anatômica de um sujeito
WO2022140646A1 (en) * 2020-12-26 2022-06-30 Mycovia Pharmaceuticals, Inc Dosing regimen for oteseconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
DK2007396T3 (da) 2006-04-03 2013-03-18 Merck Sharp & Dohme Enfumafungin-derivat som antimykotika
RS53731B1 (sr) * 2008-08-12 2015-06-30 Scynexis, Inc. Antigljivični agensi
US8188085B2 (en) 2008-08-12 2012-05-29 Merck Sharp & Dohme Corp. Antifungal agents
LT3247711T (lt) 2015-01-19 2022-05-25 Scynexis, Inc. Naujos scy-078 druskos ir polimorfai
EP3609539A1 (en) * 2017-04-10 2020-02-19 Scynexis, Inc. Antifungal agents used in combination

Also Published As

Publication number Publication date
US20200390751A1 (en) 2020-12-17
CA3071940A1 (en) 2019-02-07
TW201919476A (zh) 2019-06-01
EP4169514B1 (en) 2026-01-28
CY1125690T1 (el) 2026-02-25
HUE060508T2 (hu) 2023-03-28
MD3661503T2 (ro) 2023-01-31
CN111093655A (zh) 2020-05-01
SI3661503T1 (sl) 2023-01-31
AU2018309718A1 (en) 2020-02-27
ES2932658T3 (es) 2023-01-23
HRP20221414T1 (hr) 2023-01-20
SMT202200461T1 (it) 2023-01-13
EP4169514C0 (en) 2026-01-28
EP3661503B1 (en) 2022-09-07
EP3661503A1 (en) 2020-06-10
TWI805600B (zh) 2023-06-21
PL3661503T3 (pl) 2023-01-09
US11534433B2 (en) 2022-12-27
MA49751A (fr) 2020-06-10
MA49751B1 (fr) 2022-12-30
US20230364067A1 (en) 2023-11-16
CN118542868A (zh) 2024-08-27
LT3661503T (lt) 2022-12-12
EP4169514A1 (en) 2023-04-26
EP4732902A2 (en) 2026-04-29
WO2019028034A1 (en) 2019-02-07
RS63746B1 (sr) 2022-12-30
AU2018309718B2 (en) 2024-07-25
BR112020002290A2 (pt) 2020-09-08
MX2020001399A (es) 2020-08-06
US20260000656A1 (en) 2026-01-01
DK3661503T3 (da) 2022-12-12
JP2020529999A (ja) 2020-10-15
EA202090445A1 (ru) 2020-06-23
JP7214714B2 (ja) 2023-01-30
KR20200044823A (ko) 2020-04-29
FI3661503T3 (fi) 2022-12-15
AU2024227501A1 (en) 2024-11-07
KR102807716B1 (ko) 2025-05-13

Similar Documents

Publication Publication Date Title
GB2581913B (en) Access control in microservice architectures
SI3558169T1 (sl) Tesnilne naprave za srčno zaklopko in dovajalne naprave zanje
GB201707477D0 (en) Improvements in vehicle control
IL252368A0 (en) Antifungal agents
GB201509503D0 (en) Detecting activity in peripheral nerves
HUE071527T2 (hu) Tradipitant gasztroparézis kezelésében történõ alkalmazásra
PT3493825T (pt) Composição para aplicação tópica com atividade antifúngica
GB201618140D0 (en) Improvements in tool-path planning
GB201709666D0 (en) Detecting activity in peripheral nerves
PL3661503T3 (pl) Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph
GB201610948D0 (en) Improvements in fencing
SG10201912843YA (en) Sleep improving agent
GB201615844D0 (en) Agents for use in therapy
PL3308038T3 (pl) Korpus zaworu hydraulicznego i mechanizm zaworu hydraulicznego obejmujący korpus
GB201602933D0 (en) Improvements in sensor assemblies
PL3156706T3 (pl) Nasadka zaworowa i układ zaworowy
GB201508831D0 (en) Improvements in upper body clothing
GB201807048D0 (en) Improvements in fencing
GB2549175B (en) Valve with slot
GB201719263D0 (en) Improvements in pallets
GB201712869D0 (en) Valve with slot
GB201800055D0 (en) Improvements in Capacitoirs
GB201609122D0 (en) Anti-microbial agents and uses therefor
GB201510548D0 (en) Anti-microbial agents and uses therefor
GB201621224D0 (en) Activity sphere